Showing results (131-140 of 142) with videos related to

Sort By:
Pageof 15
Plos One|October 23, 2013
Complex patterns of chromosome 11 aberrations in myeloid malignancies target CBL, MLL, DDB1 and LMO2Thorsten Klampfl, Jelena D Milosevic, Ana Puda, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 22, 2016
Updated Outcomes and Impact of Age With Lenalidomide and Low-Dose Dexamethasone or Melphalan, Prednisone, and Thalidomide in the Randomized, Phase III FIRST TrialCyrille Hulin, Andrew Belch, Chaim Shustik, et al.
American Journal of Hematology|August 14, 2012
Clinical significance of genetic aberrations in secondary acute myeloid leukemiaJelena D Milosevic, Ana Puda, Luca Malcovati, et al.
The New England Journal of Medicine|December 12, 2013
Somatic mutations of calreticulin in myeloproliferative neoplasmsThorsten Klampfl, Heinz Gisslinger, Ashot S Harutyunyan, et al.
Blood|June 29, 2012
A prognostic model to predict survival in 867 World Health Organization-defined essential thrombocythemia at diagnosis: a study by the International Working Group on Myelofibrosis Research and TreatmentFrancesco Passamonti, Jürgen Thiele, Francois Girodon, et al.
American Journal of Hematology|November 14, 2019
Splanchnic vein thromboses associated with myeloproliferative neoplasms: An international, retrospective study on 518 casesEmanuela Sant'Antonio, Paola Guglielmelli, Lisa Pieri, et al.
The Lancet. Haematology|November 21, 2017
Image-based ex-vivo drug screening for patients with aggressive haematological malignancies: interim results from a single-arm, open-label, pilot studyBerend Snijder, Gregory I Vladimer, Nikolaus Krall, et al.
Haematologica|August 6, 2013
Comparison of placebo and best available therapy for the treatment of myelofibrosis in the phase 3 COMFORT studiesRuben A Mesa, Jean-Jacques Kiladjian, Srdan Verstovsek, et al.
Blood|June 17, 2018
Aggressive B-cell lymphomas in patients with myelofibrosis receiving JAK1/2 inhibitor therapyEdit Porpaczy, Sabrina Tripolt, Andrea Hoelbl-Kovacic, et al.
Blood|August 8, 2024
Proposals for revised International Working Group-European LeukemiaNet criteria for anemia response in myelofibrosisAyalew Tefferi, Giovanni Barosi, Francesco Passamonti, et al.
Pageof 15